Precursor T-Cell acute lymphoblastic leukemia/lymphoma with rare presentation in the urinary bladder.
Pham A, Steinberg A, Kwok B, Lopez A, Lim S, Lill M.
Hematol Rep · journal article; case reports; case-report · DOI 10.4081/hr.2011.e18 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för nelarabine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
15 träffarIn vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia.
Homminga I, Zwaan CM, Manz CY, Parker C, Bantia S, Smits WK, Higginbotham F, Pieters R, Meijerink JP.
Blood · research support, non-u.s. gov't; journal article · DOI 10.1182/blood-2011-02-337840High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Gökbuget N, Basara N, Baurmann H, Beck J, Brüggemann M, Diedrich H, Güldenzoph B, Hartung G, Horst HA, Hüttmann A, Kobbe G, Naumann R, Ratei R, Reichle A, Serve H, Stelljes M, Viardot A, Wattad M, Hoelzer D.
Blood · clinical trial, phase ii; multicenter study; journal article · DOI 10.1182/blood-2011-01-329441[Phase I study of nelarabine in patients with relapsed or refractory T-ALL/T-LBL].
Horibe K, Takimoto T, Yokozawa T, Makimoto A, Kobayashi Y, Ogawa C, Ohno R, Koh N, Katsura K, Tobinai K.
Rinsho Ketsueki · clinical trial, phase i; journal articleNew nucleoside analogs for patients with hematological malignancies.
Robak T.
Expert Opin Investig Drugs · research support, non-u.s. gov't; review; journal article · DOI 10.1517/13543784.2011.554822Treatment of acute lymphoblastic leukemia in adults.
Narayanan S, Shami PJ.
Crit Rev Oncol Hematol · review; journal article · DOI 10.1016/j.critrevonc.2011.01.014Educational paper. The development of new therapies for pediatric oncology.
Horton TM, Berg SL.
Eur J Pediatr · review; journal article · DOI 10.1007/s00431-010-1374-5Nelarabine in the treatment of refractory T-cell malignancies.
Roecker AM, Stockert A, Kisor DF.
Clin Med Insights Oncol · review-article; journal article · DOI 10.4137/cmo.s4364Towards the development of a rapid, portable, surface enhanced Raman spectroscopy based cleaning verification system for the drug nelarabine.
Corrigan DK, Salton NA, Preston C, Piletsky S.
J Pharm Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.2042-7158.2010.01152.xSalvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma.
Commander LA, Seif AE, Insogna IG, Rheingold SR.
Br J Haematol · clinical trial; research-article; journal article · DOI 10.1111/j.1365-2141.2010.08236.xA new high-performance liquid chromatography method determines low production of 9-beta-D-arabinofuranosylguanine triphosphate, an active metabolite of nelarabine, in adult T-cell leukemia cells.
Yamauchi T, Nishi R, Kitazumi K, Nakano T, Ueda T.
Oncol Rep · validation study; journal articleNelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
DeAngelo DJ.
Hematol Oncol Clin North Am · review; journal article · DOI 10.1016/j.hoc.2009.07.008Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia.
Reilly KM, Kisor DF.
Onco Targets Ther · review-article; journal article · DOI 10.2147/ott.s4770FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma.
Cohen MH, Johnson JR, Justice R, Pazdur R.
Oncologist · journal article · DOI 10.1634/theoncologist.2006-0017[Method of determination of the proteolytic activity with the aid of ninhydrin].
Kesler DF.
Lab Delo · journal article